News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,576 Results
Type
Article (88841)
Company Profile (816)
Press Release (794897)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233619)
Career Advice (4163)
Deals (40002)
Drug Delivery (179)
Drug Development (91738)
Employer Resources (207)
FDA (18565)
Job Trends (17490)
News (398794)
Policy (40018)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (239)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (565)
Approvals (18927)
Artificial intelligence (893)
ASCO (345)
Autoimmune disease (366)
Automation (66)
Bankruptcy (407)
Best Places to Work (12635)
BIO (67)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (842)
Cancer (6660)
Cardiovascular disease (561)
Career advice (3599)
Career pathing (52)
CAR-T (388)
CDC (77)
Celiac Disease (3)
Cell therapy (1083)
Cervical cancer (56)
Clinical research (79161)
Collaboration (2403)
Commercialization (1)
Company closure (8)
Compensation (1541)
Complete response letters (107)
COVID-19 (3043)
CRISPR (126)
C-suite (1309)
Cystic fibrosis (168)
Data (8815)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (97)
Diabetes (714)
Diagnostics (7615)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (443)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102507)
Editorial (80)
Employer branding (25)
Employer resources (174)
Events (138824)
Executive appointments (1203)
FDA (22701)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1977)
Gene editing (274)
Generative AI (91)
Gene therapy (859)
GLP-1 (1290)
Government (5565)
Grass and pollen (8)
Guidances (421)
Healthcare (21267)
Hematology (198)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (214)
Infectious disease (3450)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (327)
Interviews (822)
IPO (18007)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (880)
Lymphoma (481)
Machine learning (69)
Management (66)
Manufacturing (1257)
Marketing (1)
MASH (228)
Medical affairs (1)
Medical device (15289)
Medtech (15461)
Mergers & acquisitions (23313)
Metabolic disorders (1845)
mRNA (273)
Multiple sclerosis (208)
NASH (24)
Neurodegenerative disease (518)
Neuropsychiatric disorders (130)
Neuroscience (3762)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (878)
Opinion (375)
Ovarian cancer (246)
Pain (287)
Pancreatic cancer (364)
Parkinson's disease (422)
Partnered (41)
Patents (666)
Patient recruitment (776)
Peanut (71)
People (68065)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24464)
Phase 2 (34391)
Phase 3 (25855)
Pipeline (9959)
Policy (402)
Postmarket research (3560)
Preclinical (10995)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (375)
Rare diseases (1286)
Real estate (7462)
Recruiting (81)
Regulatory (30483)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (338)
Series B (244)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (138)
Weight loss (601)
Women's health (144)
Worklife (24)
Date
Today (84)
Last 7 days (465)
Last 30 days (2772)
Last 365 days (33199)
2026 (16939)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (407)
Arkansas (16)
Asia (52355)
Australia (9201)
California (14504)
Canada (4048)
China (1601)
Colorado (624)
Connecticut (645)
Delaware (450)
Europe (120729)
Florida (2164)
Georgia (470)
Hawaii (4)
Idaho (70)
Illinois (1267)
India (105)
Indiana (671)
Iowa (26)
Japan (610)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1754)
Massachusetts (10627)
Michigan (427)
Minnesota (807)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3847)
New Mexico (35)
New York (3817)
North Carolina (1951)
North Dakota (11)
Northern California (7215)
Ohio (454)
Oklahoma (27)
Oregon (55)
Pennsylvania (2849)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5697)
Tennessee (233)
Texas (2370)
United States (51921)
Utah (433)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,576 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt® System
June 23, 2026
·
4 min read
Press Releases
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
June 23, 2026
·
5 min read
Inflammatory bowel disease
Merck posts ‘encouraging’ Phase 3 ulcerative colitis data but Roche challenge looms
Given its intravenous route of administration, Merck’s tulisokibart will likely “need to be meaningfully improved” over Roche’s afimkibart, which can be given subcutaneously, BMO Capital Markets analysts said. Both assets are being tested for ulcerative colitis.
June 23, 2026
·
2 min read
·
Tristan Manalac
Obesity
Lilly’s tirzepatide will be biggest blockbuster ever, topping $70B by 2032: Evaluate
Eli Lilly’s weight-loss franchise—including the tirzepatide products Mounjaro and Zepbound, and the weight-loss pill Foundayo—will account for nearly half of the total sales of the top 10 drugs in 2032.
June 23, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate
Can ADCs be kinder and gentler? Join
BioSpace
at BIO to find out
While existing antibody-drug conjugates have been incredible advancements in cancer care, patients are ready for a better experience. At the BIO International Convention in San Diego on Thursday,
BioSpace
will lead a discussion on the next generation of ADCs.
June 23, 2026
·
3 min read
·
Annalee Armstrong
Lung cancer
Pfizer delivers ‘disappointing’ late-stage lung cancer data for ADC from $43B Seagen buy
Despite an overall survival miss, Leerink Partners said Pfizer’s antibody-drug conjugate showed “promising” signals of efficacy in a subgroup of patients who had undergone only one prior line of treatment.
June 23, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
With drug pricing now embedded in U.S. policy, business development teams in biotech and pharma are changing the way they strike deals, including acknowledging policy uncertainties with renegotiation clauses.
June 23, 2026
·
2 min read
·
Annalee Armstrong
Policy
BIO 2026: US public health as we know it is gone. Can we rebuild a better system?
Former FDA, CDC and NIH leaders convene at the BIO International Convention to discuss the dismantling of the Department of Health and Human Services under the Trump administration—and where we go from here.
June 23, 2026
·
4 min read
·
Jef Akst
Manufacturing
With onshoring ‘having a moment,’ Aquestive CEO shares lessons from 20 years of US manufacturing
Having stuck with local production in the years when offshoring to lower-cost locations was in fashion, Aquestive’s CEO is well placed to explain what the recent reshoring drive means for manufacturers.
June 23, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
June 23, 2026
·
9 min read
1 of 88,458
Next
